Combinatorial administration of molecules that simultaneously inhibit angiogenesis and invasion leads to increased therapeutic efficacy in mouse models of malignant glioma

Clinical Cancer Research

Volumn 10, Issue 13, 2004, Pages 4527-4537

  Bello, Lorenzo ^a   Lucini, Valeria ^a   Costa, Francesco ^a   Pluderi, Mauro ^a   Giussani, Carlo ^a   Acerbi, Francesco ^a   Carrabba, Giorgio ^a   Pannacci, Marilou ^a   Caronzolo, Dario ^a   Grosso, Silvia ^a   Shinkaruk, Svetlana ^b   Colleoni, Federica ^a   Canron, Xavier ^b   Tomei, Giustino ^a   Deleris, Gerard ^b   Bikfalvi, Andreas ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; MATRIX METALLOPROTEINASE; PROTEIN PEX; THROMBOCYTE FACTOR 4; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CANCER INVASION; CELL CULTURE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG POTENTIATION; ENDOTHELIUM CELL; GLIOBLASTOMA; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; APOPTOSIS; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; COLLAGEN; DISEASE MODELS, ANIMAL; DRUG COMBINATIONS; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; GLIOMA; HUMANS; LAMININ; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MICROCIRCULATION; MICROSCOPY, FLUORESCENCE; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PEPTIDES, CYCLIC; PHEX PHOSPHATE REGULATING NEUTRAL ENDOPEPTIDASE; PLATELET FACTOR 4; PROTEINS; PROTEOGLYCANS; RECOMBINANT PROTEINS; TIME FACTORS;

EID: 3042815043     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-04-0194     Document Type: Article

References (28)

1. Hahahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996;86:353-64.
2. Liotta LA, Steeg PS, Stetler-Stevenson WG. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 1997;64:327-36.
3. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases: Nature (Lond.) 2000;407:249-57.
4. Bjerkvig R, Lund-Johansen M, Edvarsen K. Tumor cell invasion and angiogenesis in the central nervous system. Curr Opin Oncol 1997;9:223-9.
5. Cao Y. Endogenous angiogenesis inhibitors and their therapeutical implications. Int J Biochem. Cell Biol 2001;33:357-69.
6. Bikfalvi A, Bicknell R. Recent advances in angiogenesis, antiangiogenesis, and vascular targeting. Trends Pharmacol Sci 2002;23:576-82.
7. Hagedorn M, Bikfalvi A. Target molecules for anti angiogenic therapy: from basic research to clinical trials. Crit Rev Oncol Hematol 2000;34:89-110.
8. Bello L, Lucini V, Carrabba G, et al. Simultaneous inhibition of glioma angiogenesis, cell proliferation, and invasion by a naturally occurring fragment of human metalloproteinase-2. Cancer Res 2001;61:8730-6.
9. Bello L, Giussani C, Carrabba G, et al. Suppression of malignant glioma recurrence in a newly developed animal model by endogenous inhibitors Clin Cancer Res 2002;8:3539-638.
10. Giussani C, Carrabba G, Pluderi M, et al. Local intracerebral delivery of endogenous inhibitors by osmotic minipumps effectively suppresses glioma growth in vivo. Cancer Res 2003;63:2499-505.
11. Hagedorn M, Zilberberg L, Wilting J, et al. Domain swapping in a COOH terminal fragment of platelet factor 4 generates potent angiogenesis inhibitors. Cancer Res 2002;62:6884-90.
12. Kunkel P, Ulbricht U, Bohlen P. Inhibition of glioma angiogenesis and growth in vivo by systemic treatment with a monoclonal antibody against vascular endothelial growth factor receptor 2. Cancer Res 2001;61:6624-8.
13. Kirsch M, Strasser J, Allende R, Bello L, Zhang J, Black PM. Angiostatin suppresses malignant glioma growth in vivo. Cancer Res 1998;58:4654-9.
14. Bello L, Carrabba G, Giussani C, et al. Low-dose chemotherapy combined with an antiangiogenic drug reduces human glioma growth in vivo. Cancer Res 2001;61:7501-6.
15. Yu JL, Rak JW, Carmeliet P, Nagy A, Kerbel RS, Coomber B. Heterogeneous vascular dependence of tumor cell populations. Am J Path 2001;158:1325-34.
16. Yu JL, Coomber BL, Kerbel RSA. paradigm for therapy induced microenvironmental changes in solid tumors leading to drug resistance. Differentiation 2002;70:599-609.
17. Pennacchetti S, Michieli P, Galluzzo M, Mazzone M, Giordano S, Comoglio PM. Hypoxia promotes invasive growth by transcriptional activation of the met proto-oncogene. Cancer Cell 2003;3:347-61.
18. Steeg PS. Angiogenesis inhibitors: motivators of metastasis? Nat Med 2003;9:822-3.
19. Friedl P, Wolf A. Tumor cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer 2003;3:362-74.
20. Hagedorn M, Zilberberg L, Lozano RM, et al. A short peptide domain of platelet factor 4 blocks angiogenic key events induced by FGF-2. FASEB J 2001;15:550-2.
21. Jouan V, Canron X, Alemany M, et al. Inhibition of in vitro angiogenesis by platelet factor 4-derived peptides and mechanism of action. Blood 1999;94:984-93.
22. Zilberberg L, Shinkaruk S, Lequin O, et al. Structure and inhibitory effect on angiogenesis and tumor development of a new vascular endothelial growth inhibitor. J Biol Chem 2003;278:35564-73.
23. Deroanne CF, Hajitou D, Calberg CM, Nusgens BV, Lapiere CM. Angiogenesis by fibroblast growth factor 4 is mediated through an autocrine up-regulation of vascular endothelial growth factor expression. Cancer Res 1997;47:5590-7.
24. Joki T, Heese O, Nikas D, et al. Expression of cyclooxygenase 2 (COX2) in human glioma and in vitro inhibition by a specific COX-2 inhibitor, NS398. Cancer Res 2000;60:4926-31.
25. Leon SP, Folkerth R, Black PM. Microvessel density is a prognostic indicator for patients with astroglial brain tumors. Cancer (Phila.) 1996;77:362-72.
26. Rao JS. Molecular mechanisms of glioma invasiveness: the role of proteases. Nat Rev Cancer 2003;3:489-501.
27. Brooks PC, Silletti S, von Schalcha TL, Friedlander M, Cheresch DA. Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity. Cell 1998;92:391-400.
28. Javerzat S, Auguste P, Bikfalvi A. The role of fibroblast growth factors in vascular development. Trends Mol Med 2002;8:483-9.